LEPU ScienTech Medical Technology (Shanghai) Past Earnings Performance
Past criteria checks 3/6
LEPU ScienTech Medical Technology (Shanghai) has been growing earnings at an average annual rate of 9.4%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 21.7% per year. LEPU ScienTech Medical Technology (Shanghai)'s return on equity is 7.9%, and it has net margins of 46.5%.
Key information
9.4%
Earnings growth rate
1.0%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 21.7% |
| Return on equity | 7.9% |
| Net Margin | 46.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital
Mar 03
The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence
Nov 09LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit
Aug 14Revenue & Expenses BreakdownBeta
How LEPU ScienTech Medical Technology (Shanghai) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 326 | 152 | 87 | 62 |
| 30 Sep 23 | 307 | 92 | 86 | 61 |
| 30 Jun 23 | 289 | 32 | 85 | 61 |
| 31 Mar 23 | 268 | 6 | 81 | 57 |
| 31 Dec 22 | 248 | -20 | 78 | 54 |
| 30 Sep 22 | 242 | 11 | 81 | 49 |
| 30 Jun 22 | 236 | 41 | 85 | 45 |
| 31 Mar 22 | 230 | 50 | 78 | 43 |
| 31 Dec 21 | 223 | 59 | 71 | 41 |
| 31 Dec 20 | 148 | 69 | 28 | 39 |
| 31 Dec 19 | 116 | 52 | 30 | 26 |
Quality Earnings: 2291 has high quality earnings.
Growing Profit Margin: 2291 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2291's earnings have grown by 9.4% per year over the past 5 years.
Accelerating Growth: 2291 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2291 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.2%).
Return on Equity
High ROE: 2291's Return on Equity (7.9%) is considered low.